Journal of Cancer Research and Therapeutics Close
 

Figure 1: The media progression-free survival (PFS) was 11 months (95% confidence interval, 10.035-11.965) in the oligometastatic patients and 6 months in the polymetastatic patients (P < 0.05). The PFS curves after the treatment for recurrence

Figure 1: The media progression-free survival (PFS) was 11 months (95% confidence interval, 10.035-11.965) in the oligometastatic patients and 6 months in the polymetastatic patients (<i>P</i> < 0.05). The PFS curves after the treatment for recurrence